- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
GU Cancers Symposium 2013 - Improving active surveillance: The emerging role of biomarkers
February 14, 2013
GU Cancers Symposium 2013 - The pathology perspective on available tools for active surveillance
February 14, 2013
GU Cancers Symposium 2013 - The imaging perspective on available tools for active surveillance
February 14, 2013
GU Cancers Symposium 2013 - Treatment and surveillance of prostate cancer patients - Symposium Summary
February 14, 2013
Impact of rectal balloon-filling materials on the dosimetry of prostate and organs at risk in photon beam therapy - Abstract
February 14, 2013
Access to information and expectations of treatment decisions for prostate cancer patients - results of a European survey - Abstract
February 14, 2013
Endocrine therapy in prostate cancer: Time for reappraisal of risks, benefits and cost-effectiveness? - Abstract
February 14, 2013
A review of emerging strategies for optimizing the clinical impact of immunotherapeutic agents in prostate cancer
February 14, 2013
Landmark survey of prostate biopsies confirms sampling standard
February 14, 2013
Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: Patient considerations, novel opportunities, and future directions - Abstract
February 13, 2013
Dosimetric assessment of prostate cancer patients through principal component analysis (PCA) - Abstract
February 13, 2013
Risk stratification after biochemical failure following curative treatment of locally advanced prostate cancer: Data from the TROG 96.01 trial - Abstract
February 13, 2013
Trans-anal rectoscopic ball diathermy (TARD) for radiotherapy induced haemorrhagic telangectasia : A safe and effective treatment - Abstract
February 13, 2013
Diagnostic tests in urology: Magnetic resonance imaging (MRI) for the staging of prostate cancer - Abstract
February 13, 2013